{"id":30032,"date":"2026-04-27T02:29:18","date_gmt":"2026-04-27T02:29:18","guid":{"rendered":"https:\/\/indiabulletinusa.com\/wordpress\/2026\/04\/27\/sun-pharma-strikes-11-75-billion-deal-to-acquire-u-s-firm-organon\/"},"modified":"2026-04-27T02:29:18","modified_gmt":"2026-04-27T02:29:18","slug":"sun-pharma-strikes-11-75-billion-deal-to-acquire-u-s-firm-organon","status":"publish","type":"post","link":"https:\/\/indiabulletinusa.com\/wordpress\/2026\/04\/27\/sun-pharma-strikes-11-75-billion-deal-to-acquire-u-s-firm-organon\/","title":{"rendered":"Sun Pharma Strikes $11.75 Billion Deal to Acquire U.S. Firm Organon"},"content":{"rendered":"<p><br \/>\n<\/p>\n<h3>Sun Pharma to Acquire Organon in Major Deal<\/h3>\n<p><strong>SHANGHAI, CHINA<\/strong> \u2013 Sun Pharmaceutical Industries, based in India, has announced a significant acquisition of Organon &amp; Co, a company located in New Jersey, for an all-cash deal valued at approximately $11.75 billion, including debt.<\/p>\n<p>Sun Pharma will purchase all of Organon\u2019s outstanding shares at $14 each. This decision comes after a thorough evaluation of strategic options, as noted by Carrie Cox, the executive chair at Organon. She emphasized that the deal offers immediate and significant value for Organon\u2019s shareholders.<\/p>\n<p>Organon, which was spun off from Merck in 2021, focuses on women&#8217;s health and biosimilars, boasting over 70 products available in 140 countries worldwide. This move positions Sun Pharma, India&#8217;s leading drug manufacturer, among the top 25 global pharmaceutical companies, with projected revenues of $12.4 billion.<\/p>\n<p>Kirti Ganorkar, the managing director at Sun Pharma, mentioned that this acquisition is a strategic step towards enhancing the company&#8217;s global presence. With the U.S. being a key market, the buyout is expected to boost Sun Pharma\u2019s product lineup.<\/p>\n<p>Sun Pharma aims to grow its innovative medicines segment, which currently includes products in dermatology, ophthalmology, and onco-dermatology. For the financial year ending March 2025, this sector contributed 20% to Sun Pharma\u2019s total sales, and the acquisition is anticipated to increase that contribution to 27%.<\/p>\n<p>Dilip Shanghvi, the executive chairman of Sun Pharma, highlighted that Organon\u2019s offerings, reach, and capabilities will complement Sun Pharma\u2019s existing portfolio well.<\/p>\n<p>Organon operates in several key markets, including the U.S., Europe, China, Canada, and Brazil, and has six manufacturing sites in the EU and emerging markets.<\/p>\n<p>In the market response, Organon\u2019s shares surged by nearly 31% on Friday, while Sun Pharma\u2019s shares experienced a slight decline of 3.6%.<\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>Sun Pharma to Acquire Organon in Major Deal SHANGHAI, CHINA \u2013 Sun Pharmaceutical Industries, based in India, has announced a significant acquisition of Organon &amp; Co, a company located in New Jersey, for an all-cash deal valued at approximately $11.75 billion, including debt. Sun Pharma will purchase all of Organon\u2019s outstanding shares at $14 each.<\/p>\n","protected":false},"author":1,"featured_media":30033,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"footnotes":""},"categories":[28],"tags":[6040,113,471,38954,18178,38953,38952,950],"class_list":{"0":"post-30032","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-india-news","8":"tag-asia-economy","9":"tag-business-news","10":"tag-india","11":"tag-merck-co-inc","12":"tag-new-jersey","13":"tag-organon-co","14":"tag-sun-pharmaceutical-industries-ltd","15":"tag-united-states"},"_links":{"self":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts\/30032","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/comments?post=30032"}],"version-history":[{"count":0,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/posts\/30032\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/media\/30033"}],"wp:attachment":[{"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/media?parent=30032"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/categories?post=30032"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/indiabulletinusa.com\/wordpress\/wp-json\/wp\/v2\/tags?post=30032"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}